We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

66 hedge funds and large institutions have $132M invested in Enanta Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 15

51% more capital invested

Capital invested by funds: $87.3M → $132M (+$44.4M)

22% more funds holding

Funds holding: 54 → 66 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

41% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 22

Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
27
Increased
13
Reduced
22
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.5M
2
CCM
Consonance Capital Management
New York
+$6.83M
3
Millennium Management
Millennium Management
New York
+$2.61M
4
SM
Sabby Management
Florida
+$2.08M
5
EI
EAM Investors
California
+$1.64M

Top Sellers

Rank Fund Capital Flow
1
AP
AlpInvest Partners
Netherlands
-$9.18M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$7.43M
3
Franklin Resources
Franklin Resources
California
-$5.62M
4
SONJCPFA
State of New Jersey Common Pension Fund A
New Jersey
-$2.58M
5
SCM
Sigma Capital Management
Connecticut
-$1.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
NI
26
Numeric Investors
Massachusetts
$1.09M +$965K +39,800 New
TCIM
27
TIAA CREF Investment Management
New York
$970K +$503K +20,755 +140%
Wells Fargo
28
Wells Fargo
California
$857K +$340K +14,026 +81%
Ameriprise
29
Ameriprise
Minnesota
$846K -$104K -4,308 -12%
SFM
30
Sphera Funds Management
Israel
$690K +$613K +25,292 New
Geode Capital Management
31
Geode Capital Management
Massachusetts
$582K -$3.95K -163 -0.8%
HAMF
32
Hatteras Alternative Mutual Funds
North Carolina
$488K +$434K +17,900 New
AI
33
Analytic Investors
California
$478K +$424K +17,504 New
Prudential Financial
34
Prudential Financial
New Jersey
$411K +$365K +15,070 New
EMG
35
Ellington Management Group
Connecticut
$314K +$279K +11,500 New
NFA
36
Nationwide Fund Advisors
Ohio
$290K -$2.4K -99 -0.9%
BIM
37
BlackRock Investment Management
Delaware
$276K -$121 -5 -0%
Citadel Advisors
38
Citadel Advisors
Florida
$276K +$245K +10,113 New
CAM
39
Cormorant Asset Management
Massachusetts
$273K +$242K +10,000 New
CS
40
Credit Suisse
Switzerland
$264K +$234K +9,661 New
Goldman Sachs
41
Goldman Sachs
New York
$260K -$969 -40 -0.4%
SO
42
STRS Ohio
Ohio
$237K -$24.2K -1,000 -10%
Charles Schwab
43
Charles Schwab
California
$208K -$225K -9,284 -55%
California State Teachers Retirement System (CalSTRS)
44
California State Teachers Retirement System (CalSTRS)
California
$178K – – –
Morgan Stanley
45
Morgan Stanley
New York
$170K +$151K +6,225 New
Asset Management One
46
Asset Management One
Japan
$134K +$116K +4,786 New
TA
47
Teachers Advisors
New York
$125K – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$117K +$104K +4,300 New
Bank of America
49
Bank of America
North Carolina
$80K +$70.5K +2,909 +11,188%
Deutsche Bank
50
Deutsche Bank
Germany
$73K -$355K -14,630 -84%
1
2
3 4

ENTA Hedge Fund Activity: Q4 2013 in Review

66 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q4 2013, worth a combined $132M — up 51% from $87.3M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ENTA positions and 15 closed out — a net gain of 12 holders — while 13 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $31.5M. The largest seller was AlpInvest Partners, cutting an estimated $9.18M.

  • 66 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q4 2013, up from 54 in Q3 2013.
  • Funds reported $132M of Enanta Pharmaceuticals stock for Q4 2013, up 51% quarter-over-quarter.
  • 27 funds opened new Enanta Pharmaceuticals positions in Q4 2013 and 15 closed out, a net change of +12 holders.
  • The largest Enanta Pharmaceuticals buyer in Q4 2013 was Fidelity Investments, an estimated $31.5M added.
  • The largest Enanta Pharmaceuticals seller in Q4 2013 was AlpInvest Partners, an estimated $9.18M sold.

Based on aggregated 13F filings for Q4 2013.